Fate Therapeutics, Inc. (FATE)
Detailed information about the stock.
Price: $1.71(11.76%)
Open: $1.51
High: $1.81
Low: $1.43
Volume:5.6M
Sector: Healthcare
Industry: Biotechnology
Market Cap: 194.8M
P/E Ratio:
P/S Ratio: 14.48
P/B Ratio: 0.54
PEG Ratio:
Return on Equity: -46.59%
Return on Assets: -22.11%
Profit Margin: 0.00%
Gross Margin: 0.00%
Operating Margin: -1703.87%
Debt to Equity: 27.32
Current Ratio: 8.29
Quick Ratio: 8.10
Beta: 2.02
VWAP: 1.43
50-Day Moving Avg: 1.59
200-Day Moving Avg: 3.03
Bollinger Bands Upper: 1.57
Bollinger Bands Lower: 1.13
ATR: 0.14
RSI: 78.84
Price History
Compare up to two tickers at a time.
Pair Details
Information about the selected stock pair.
Pair:
Correlation:
Rolling Correlation:
Cointegration:
Rolling Cointegration:
Hedge Ratio:
Spread Moving Avg:
Spread Std Dev:
Average Price Difference:
Z-Score:
Half-Life:
Rolling Beta:
Related Tickers
Stocks in the same sector or industry.
Symbol | Name | Price | Change | Sector | Industry | Correlated | Cointegrated | Actions |
---|
ARVN | Arvinas, Inc. | $18.54 | | Healthcare | Biotechnology | | | |
BEAM | Beam Therapeutics Inc. | $34.09 | | Healthcare | Biotechnology | | | |
NKTX | Nkarta, Inc. | $2.29 | | Healthcare | Biotechnology | | | |
NTLA | Intellia Therapeutics, Inc. | $12.28 | | Healthcare | Biotechnology | | | |
SANA | Sana Biotechnology, Inc. | $3.09 | | Healthcare | Biotechnology | | | |